SJ

Steve Jurvetson

Future Ventures
Venture Capital LinkedIn Twitter/X
#294
LinkedIn Rank
144
Benchmarker Score
4
Posts
126
Likes
6
Comments
32
Avg Likes
2
Avg Comments
132
Total Engagement
33
Engagement Rate
2.3
Posts/Week
Every few days
Posting Regularity
Metrics are based on tracked posts and calculated averages. Actual performance may vary.
105,067 followers

Data last refreshed: February 16, 2026

Engagement metrics shown below reflect data as of this date. Current LinkedIn stats may differ.

Recent Posts

4 posts

Generative AI works best when solutions are hard to find, but easy to verify. For AI-driven drug development, the challenge has been our complex systems biology making tox and off-target effects h...

Portfolio Company Wins Article Generative AI Drug Discovery Biotech Jan 31, 2026 View on LinkedIn
23
Likes
0
Cmnts
0
Reposts

Now and then... The Foresight Institute's Vision Weekend is still going strong — a veritable "brain spa" of futurism. Well, it's back to the Future this December: https://lnkd.in/gT-CGPNc + a ti...

Events & Speaking Engagements Image Deep Tech Oct 01, 2025 View on LinkedIn
49
Likes
6
Cmnts
1
Reposts

The Stanford interview on AI futures just went live, free here: https://lnkd.in/g-qtBQJx "Steve Jurvetson, An Estonian immigrant’s son reflects on a life shaped by technology: inspired by his fath...

Thought Leadership & Future Outlook Image Artificial Intelligence Semiconductors Edge AI AI Agents Robotics Sep 26, 2025 View on LinkedIn
37
Likes
0
Cmnts
0
Reposts

Printing a vast array of externalized human lymph nodes is a great platform for high-throughput experimentation for AI learning loops. Big pharma agrees.

Thought Leadership & Future Outlook Article Artificial Intelligence Drug Discovery Biotech Synthetic Biology Sep 24, 2025 View on LinkedIn
17
Likes
0
Cmnts
0
Reposts

Rank History

16 Feb 2026
#38
24 Jan 2026
#40
24 Jan 2026
#40

Content Categories

Thought Leadership & Future Outlook 2
Portfolio Company Wins 1
Events & Speaking Engagements 1

Topics & Themes

Artificial Intelligence Drug Discovery Biotech Deep Tech Semiconductors Edge AI AI Agents Robotics Synthetic Biology Generative AI

Top Quartile Benchmarks

Based on top 94 of 375 in Venture Capital

Posts
43
Steve: 46 ↑
Likes
20,660
Steve: 25,997 ↑
Comments
1,510
Steve: 1,523 ↑
Avg Likes
303.6
Steve: 565.2 ↑
Avg Comments
21.7
Steve: 33.1 ↑
Benchmarker Score
25,190
Steve: 30,566 ↑
Posts/Week
2.9
Steve: 2.3 ↓
Avg Post Length
405 chars
Steve: 1,305 ↑
Trending Topics (Top Quartile)
Artificial Intelligence Regulation & Policy Industry Trends Founder Journey Fundraising